Cantel Medical Joins S&P SmallCap 600 Index

LITTLE FALLS, N.J.—Cantel Medical Corp. announced Nov. 13 that it will be added to the S&P SmallCap 600 Index on a date to be announced by Standard & Poor's.

This index covers approximately 3 percent of the domestic equities market and is designed to be an efficient portfolio of companies that meet specific inclusion criteria to ensure that they are investable and financially viable.

Criteria for addition to the S&P SmallCap 600 Index includes a market capitalization in the range of $200 million to $1 billion, four consecutive quarters of positive GAAP Net Income, a public float of at least 50 percent  and a ratio of annual dollar value traded to market capitalization of 0.30 or greater.

"We are pleased that the S&P Index Committee has selected us for inclusion in the S&P SmallCap 600,” said Cantel's President and CEO Andrew Krakauer. “This listing recognizes our market capitalization, financial viability, public float and strong liquidity and provides us with additional visibility as a market leader in the healthcare industry."